Columbus Prostate Cancer Center is the First Prostate-Only Treatment Center in United States to Earn ACR-ASTRO Accreditation

COLUMBUS, Ohio, Sept. 23, 2011 /PRNewswire-iReach/ -- The Columbus Prostate Cancer Center  (CPCC), a partnership between AKSM/Oncology and Central Ohio Urology Group, has earned the distinction of being the first ever prostate-only treatment center in United States to be awarded a three-year term of accreditation in radiation oncology. This high honor was bestowed upon CPCC as the result of a recent review by the American College of Radiology (ACR) and The American Society for Radiation Oncology (ASTRO).

(Photo:  http://photos.prnewswire.com/prnh/20110923/CG74308)

The ACR-ASTRO seal of accreditation represents the highest level of quality and patient safety. It is awarded only to facilities meeting specific Practice Guidelines and Technical Standards developed by ACR and ASTRO after a peer-review evaluation by board-certified radiation oncologists and medical physicists who are experts in the field.

"Delivering the highest quality of care has always been a priority for the urologists within Central Ohio Urology Group," said practice president Paul Kaufman, MD. "This accreditation is not required, but we were determined to undergo this vigorous review to assure we delivered the highest quality of care. We firmly believe being recognized with such distinction demonstrates our commitment to quality and excellence, not only to our patients, but to the greater community as well."

During CPCC's review and on-site survey, patient care and treatment, patient safety, personnel qualifications, adequacy of facility equipment, quality control procedures, and quality assurance programs were assessed. CPCC received an unqualified recommendation which means there were no deficiencies that needed improvement.

AKSM/Oncology both manages and staffs CPCC and is the market leader providing radiation therapy services in conjunction with urologists throughout the United States. AKSM/Oncology spent years planning and creating prostate-only treatment centers in partnership with urologists and radiation oncologists to assure the highest clinical standards and protocols were adopted and implemented. "Clinical quality is an ongoing process that requires diligence and commitment of all the parties," said AKSM/Oncology National Clinical Director Donald Jackson. "We set the standards high and deliver on our promise – that's what makes our centers unique from coast to coast." Jackson also stated that CPCC is the first of numerous AKSM/Oncology-operated centers that will be seeking ACR accreditation.

The ACR is a national professional organization serving more than 34,000 diagnostic/interventional radiologists, radiation oncologists, nuclear medicine physicians, and medical physicists with programs focusing on the practice of medical imaging and radiation oncology and the delivery of comprehensive health care services. ASTRO is a professional organization serving more than 10,000 radiation oncologists, medical physicists and other health care professionals involved in the treatment of cancer patients.

AKSM/Oncology is a urologist-owned and operated company that has earned a national reputation for its radiation center expertise. AKSM/Oncology, Inc. is a subsidiary of AKSM, Ltd. a national provider of technology and services by urologist for urologists since 1986.

Central Ohio Urology Group is a twenty-six member urology group with 15 locations throughout greater Columbus.

Media Contact: Gary Stelluti Health Care Marketing Strategies, LLC, 614-775-9659, [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Health Care Marketing Strategies, LLC